We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » One in 10 Drugs Approved by FDA Did Not Achieve All Trial Endpoints, Researchers Say
One in 10 Drugs Approved by FDA Did Not Achieve All Trial Endpoints, Researchers Say
Ten percent of new drug approvals in the U.S. from 2018 to 2021 were based on pivotal studies that failed to meet at least one primary endpoint, according to a new report that concludes the FDA needs to be more transparent about its approval decisions.